Vimarsana
Biggest News Aggregation in the World

Page 2 - Leonard Post News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Leonard Post. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Leonard Post Today - Breaking & Trending Today

Vivace Therapeutics announces dosing of first cohort of patients with its first-in-class TEAD inhibitor - Vimarsana News

Vivace Therapeutics announces dosing of first cohort of patients with its first-in-class TEAD inhibitor

Share this article Share this article SAN MATEO, Calif., May 4, 2021 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the completion of enrollment of the first cohort of patients being treated with VT3989 in its Phase 1 clinical study. The Company anticipates enrolling the next higher dose cohort in the second part of May.   The VT3989 Phase 1 study is now open at centers in both the US and Australia (https://clinicaltrials.gov/ct2/show/NCT04665206) to evaluate the s...

Athena Therapeutics Announces Initial Financing From HighCape Capital And Connecticut Innovations - Vimarsana News

Athena Therapeutics Announces Initial Financing From HighCape Capital And Connecticut Innovations

Athena Therapeutics Announces Initial Financing From HighCape Capital And Connecticut Innovations Share Article NEW HAVEN, Conn. (PRWEB) December 17, 2020 Athena Therapeutics today announced the closing of an initial financing round with HighCape Capital and Connecticut Innovations. This round of funding will provide the necessary resources to create an innovative cancer drug company that combines world-class scientists, powerful intellectual property, support from Yale University, and a leadership team with extensive experience...

Source: prweb.com